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Summary  
|~i::order to address the issue of the role of mast cells and nitric oxide (NO) in joint effusions occurring in the course 
of osteoarthritis (OA), synovial fluids collected from the knee of patients with OA, articular chondrocalcinosis and 
rheumatoid arthritis (RA) were studied for number of mast cells, and histamine, tryptase, phospholipase A2 and nitrite 
~0ntent. Mast cell counts are elevated in synovial fluid from OA patients when compared with RA. Histamine 
content in synovial fluid parallels the number of mast cells. Tryptase levels are elevated in OA in comparison with 
both other conditions, but do not reach the level of significance. Identical phospholipase A2 levels are recorded in 
three groups. Nitrite concentrations are also higher in synovial fluid from OA patients when compared with RA 
patients. These results suggest hat mast cells in association with various inflammatory cells, may contribute to 
inflammation and cartilage breakdown in OA. 
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Int roduct ion 
CLINICAL features of osteoarthrit is (OA) may vary 
according to mechanical, metabolic or environ- 
mental conditions constituting risk factors in an 
individual patient. Despite the fact that the initial 
alteration in OA can be located in joint cartilage, 
changes of subchondral bone, osteophytosis and 
synovial inflammatory reactions are important 
in the  course of the disease and are produced as 
a consequence of the action of various mediators. 
Art icular chondrocalcinosis (ACC) is charac- 
terized by calcium crystal deposits in cartilage 
tissue. 
Cartilage breakdown can be related to the 
secretion of abnormal matrix components by 
dysregulated and mutant chondrocytes. Degrading 
substances, such as metalloproteinases al o con- 
tribute to cartilage alterations [1]. 
Interactions between synovial membrane 
cells and cartilage are extremely important for 
explaining the occurrence of cartilage alterations 
and flares in the course of OA. Production of 
interleukins (IL), especially IL-1 and TNF-~ by 
synovial cells is well documented, and these 
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mediators can activate chondrocytes as well as 
synovial cells [2]. 
During the course of the disease, a great number 
of OA patients suffer from joint effusions, 
especially in the knee, with pain and disability, and 
often require a treatment with intra-art icular 
corticosteroid injections. 
The presence of mast cells (MC) has been 
recorded in synovial fluid (SF) or synovial mem- 
brane, especially in rheumatoid arthrit is (RA) 
[3-8]. However MC are less numerous than other 
cells such as polymorphonuclear cells, macro- 
phages or lymphocytes. Indeed, this finding may be 
of importance in view of the recognized role of 
these cells in both acute and chronic inf lammatory 
processes. Nevertheless, the exact role of MC 
in synovial inflammation in human disease is not 
yet elucidated. Upon activation either through the 
high affinity receptor for IgE immunoglobulin 
(Fce R1) or upon action of cytokines, MC release 
preformed mediators such histamine and the 
proteolytic enzyme tryptase. Newly synthesized 
mediators are also released, and phospholipase A2 
(PLA2) activation is an important initial element 
of the biochemical cascade leading to the synthesis 
of arachidonic acid derived mediators. 
Nitric oxide (NO) was recently identified as 
a potent mediator of inflammatory reactions, in 
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view of its vasodilating properties. It is produced 
by many cell types including endothelial cells, 
macrophages, mast cells, neutrophil polymorpho- 
nuclear cells and platelets. It is rapidly degraded 
into nitrites and nitrates in biological fluids. 
In order to address the issue of the role of MC 
and NO in the genesis of joint effusions in OA, SF 
from patients with OA, ACC and RA were studied 
for number of MC, histamine, tryptase, PLA2 and 
nitrite content. 
Pat ients  and  Methods  
SF 
SF were obtained from the knee under sterile 
procedure during arthrocentesis or arthroscopy for 
diagnostic purposes, collected in heparinized tubes 
and centrifuged. A visual count of the cells using 
a hemocytometer was done to insure that the 
supernatant had been rendered cell-free. The 
supernatants were stored at -80°C, and sub- 
sequently assayed for mediators. 
The total number of patients was 51 (33 women 
and 18 men). The diagnosis of OA Was made in 
16 patients (nine females, seven males, mean age 
68.6 _+ 10.3) on the association of joint space 
narrowing, erosions and osteophytes on X-rays, in 
the absence of clinical, biological or radiological 
signs suggesting an inflammatory rheumatism. 
The diagnosis of ACC was made in presence of 
calcium deposition in articular cartilage on X-rays 
and presence of calcium pyrophosphate crystals in 
SF by microscopic examination. Fourteen patients 
(eight women and six men, mean age 76.3 _+ 15.4) 
were included in this group. 
The diagnosis of RA was made in 21 patients (16 
women and five men, mean age 57.5 _+ 6) on the 
basis of American Rheumatism Association revised 
criteria for RA [9]. These patients were included in 
the study, as synovial effusions are frequently 
observed in this chronic joint disease wi th  an 
immunological background. All RA patients had 
an active disease at the time of examination, and 
received a treatment by disease modifying anti- 
rheumatic drugs, along with non-steroidal anti- 
inflammatory drugs, and in some cases oral 
corticosteroids. 
MC ENUMERATION 
Cytocentrifuge preparation of SF was made 
immediately after collection, fixed in methanol 
and stained with Alcian blue/safranin. In the 
first experiments, blue toluidine staining was also 
used and gave similar results than alcian/safranin 
staining. The first 500 cells encountered in 
random high power fields (x50, oil immersion) were 
observed and counted. The proportion of MC was 
derived as a percentage of all nucleated cells. 
HISTAMINE 
Histamine levels in SF were determined using 
the fluorometric method of Shore [10] modified 
with an automated continuous-flow technique [11]. 
The limit of detection was 500 pg/ml for samples of 
230 #1. The reproducibility was _+2% for concen- 
trations below 2 ng/ml. Results are expressed in 
ng/ml. Extensive tests for specificity are reported 
in [11]. 
In order to ascertain the absence of histaminase 
in SF, a known amount of histamine (1.2, or 
4 ng/ml) was added to five histamine-free synovial 
fluids. The samples were incubated 3 h at 37°C and 
tested again for the presence of histamine. Hista- 
mine was detected in all the samples tested. 
TRYPTASE 
Tryptase was assayed using a solid-phase 
radio-immuno-assay based on the use of an anti~ 
human tryptase monoclonal antibody (Pharmacia 
Tryptase RIACT ~', Kabi Pharmacia, Uppsala, 
Sweden) [12]. Results are expressed in U/ml. 
PLA2 
Extracellular PLA2 activity was determined 
using the fluorometric method described by 
Radvanyi et al. [13] using as a substrate the 
l-hexadecanoy]-2-(1-pyrenyldecanoyl)-sn-glycero-3- 
phospho-g]ycerol (Mo]ecular Probes Inc., USA). 
The fluorescent phospholipid was suspended in 
ethanol at a concentration f 0.2 raM; vesicles were 
prepared by adding the phospho]ipid dissolved in 
ethanol to an aqueous medium. The reaction 
solution was prepared by adding sequentially i ml 
buffer containing 50 mM Tris-HCl pH 7.5, 100 mM 
NaCl, and ] mM EDTA, I0 p] of substrate (2 mM 
final concentration), 10#I of serum albumin 
solution (0.1% final concentration), 6 #l of 1 M 
CaC12 (6 mM final concentration). 
The fluorescence of the reaction medium was 
recorded (as blank) and the reaction was initiated 
by the addition of the phospholipase. The activity 
in nM/min was calculated according to the formula: 
A=2×10-4 (S-S°)V 
Fmax 
S is defined as the slope of the curve representing 
the increase of fluorescence vstime. S ° is the slope 
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observed in the absence of the enzyme (blank). 
:~;i:i!S:::the volume (#l) of pyrene phospholipid 
(0:2:m~) in the reaction medium and F~x the 
maximum f luorescence signal at the end of the 
react ion  in:i:ii:iipresence of 5#g PLA2 from Naja 
naj~ii::i(Sig~:ia i Chem., St Louis, MO, U.S.A.). All 
f lu~es~:eh~; measurements were done with a 
j~iiiii~!i:::~v0n JY three-dimension spectrofluoro- 
me~e~!~uipped with a Xenon lamp. The fluor- 
~:~e~::::::::ii:ihtensity was monitored using excitation 
~( : ! : :e~ion  wavelengths of 345 nm and 398 nm 
:respectively. PLA2 activity is expressed as nmol/ 
min/ml. 
NITRITE 
Nitr ite concentrations were measured by a 
color±metric method using the Griess reaction as 
described in [14]. The nitrite concentration is 
expressed in nmol/ml. 
STATISTICS 
Mean values of the biological parameters were 
compared between groups using the Wilcoxon's 
test. 
Resu l ts  
As expected, cell counts are significantly lower 
in SF from patients with OA or ACC than in SF 
from RA patients. MC counts are elevated in SF of 
OA when compared with RA. Histamine content in 
SF parallels the number of MC. The histamine 
concentration i SF is significantly higher in OA 
than in RA and in ACC (P < 0.05). Tryptase levels 
are elevated in OA in comparison with both other 
conditions, but do not reach the level of signifi- 
cance. Identical PLA2 levels are recorded in three 
groups. Nitrite concentrations are also higher in 
SF from OA patients, compared with RA patients. 
(Table I). 
Discuss ion  
Pathophysiological mechanisms of inflammation 
and synovial effusion in OA are still uncertain, but 
MC are likely to play a role. Previous cytological 
studies of SF have shown that MC numbers are 
elevated in OA when compared with normal 
controls or with RA [8]. MC from OA synovia were 
reported to contain and release more histamine 
than MC from RA synovia [6]. 
This work aimed at further evaluating the role 
of MC in OA and in ACC by means of MC counts 
in SF and by assaying mediators released by these 
cells into the SF. In order to appreciate the relative 
role of various cells, assays were performed for 
histamine, a mediator released by MC and 
polymorphonuclear basophils, tryptase, a MC 
specific mediator, PLA2, an enzyme produced by 
various inflammatory cells, and nitrite, as a 
metabolic endpoint of nitric oxide. Interpretat ion 
of the results is made difficult by the lack of 
data concerning normal controls. Thus we chose 
to compare three pathological conditions, being 
conscious of the drawback of this method concern- 
ing the significance of the results. 
If one considers the percentage of MC, our 
results are very comparable with those reported by 
Dean et al. [8]. These authors found 0.029% in RA, 
vs 0.03% in our patients, and 0.84% in established 
OA vs 0.2% in our patients. Nevertheless, they did 
not calculate the absolute number of MC in SF. 
Our results show that the absolute MC number in 
RA (4620 cells/ml) is superior to the MC number 
in OA (1340cells/ml) because of the higher 
nucleated cell concentration in RA fluids. The 
results of histamine assay show that histamine 
concentration in OA fluid is elevated when 
compared with RA. 
Several considerations may help to explain this 
apparent discrepancy. Enumerating MC either in 
biological fluids or on histological tissue sections 
bears an inevitable error, because of the fact 
Table I 
Mast cell activation products and h[trites in synovial fluid 
Percentage of mast cells 
Total number of nucleated cells (×10S/ml) 
Histamine (ng/ml) 
Tryptase (U/ml) 
Phospholipase A2 (nM/min/ml) 
NO_~ (nM/ml) 
Osteoarthritis Chondrocalcinosis Rheumatoid arthritis 
N= 16 N= 14 N=21 
20 ± 10 ND 3 ± 7 
0.67** ± 0.9 2.8** ± 6.0 15.4 _+ 9.8 
10.4 ± 9.9* 8.7 ± 4.9* 5.1 ± 4.2 
3.5 ± 13,3 0.35 ± 0.6 0.35 ± 1.4 
31.7 ± 13.3 22.5 + 13.2 36.3 __+ 21 
0.56 ± 0.3 0.38 ± 0.2 0 ± 0 
(N= 6) (N= 6) (N= 12) 
Results are given as mean + S.D. *P=0.05 vs RA. **P=0.01 vs RA. 
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that activated MC, i.e. MC which are liable to 
be responsible for the disease, are not accessible 
to the count because they are partially or totally 
degranulated, and consequently poorly or not 
stained. In our experience, MC enumeration i SF 
from ACC patients was not possible because of 
technical difficulties linked to the high viscosity of 
the material. 
Histamine is generally considered a mast 
cell originated mediator, but polymorphonuclear 
basophils are also able to contribute to the hista- 
mine content of a biological fluid. 
Tryptase is a proteolytic enzyme, which is 
specifically located in and released by MC. Among 
the different diseases here studied, ~OA was the 
only one in which tryptase was detected in 
significant levels. Because tryptase is normally 
absent in biological fluid and released by MCS upon 
action of various stimuli, the presence of this 
substance is in itself of significance. Further- 
more, in the case of RA and ACC, several fluid 
samples were totally devoid of assayable tryptase. 
When histamine release is not accompanied with 
detectable tryptase levels, an occurrence observed 
in ACC, a possible role of polymorphonuclear 
basophils may be hypothesized, but the identifi- 
cation of these cells in the fluid by optical 
observation was made impossible by technical 
difficulties. 
In OA, the presence of histamine and tryptase 
in SF at higher concentrations than in ACC or 
RA, despite the lower mean MC count, suggests 
the activation of these cells. Or alternatively the 
presence of inhibitors of tryptase or histamine in 
RA SF (which would cause problems with the 
measurement of these products), or the presence of 
proteases able to degrade them could account 
for the higher concentrations in OA compared with 
RA. However in our experiments, the detection of 
the histamine previously added to SF was not 
in favor of the presence of histaminase. The 
proteases are likely to be present also in OA SF. 
Further experiments will have to be done to clarify 
this issue. 
The demonstration f MC activation products in 
SF raises the question of activation mechanisms. 
In view of the demonstration that MC can be 
activated or modulated by various lymphokines or 
cytokines, the role of these mediators appears 
likely [15-17]. 
On the other hand PLA2 assay yielded very 
similar results in three of the conditions tudied, 
presumably because PLA2 activation develops in 
various cells and represents a feature of a common 
activation pathway occurring in inflammatory 
cell membrane and leading to platelet aggregat- 
ing factor (PAF) and arachidonic ac id  derived 
mediators. 
Nitrite levels were elevated in OA and in ACC 
fluids, suggesting that NO release is involved in 
synovial inflammation in OA. Further study is 
necessary to precisely identify the cellular origin 
of NO, but the presence of this mediator may 
help explain vasodilatation and fluid leakage 
into the joint. In contrast, nitrites were not 
detected in either serum or SF from RA patients. 
This result may correspond to nitrite levels below 
the detection threshold of the method, but an 
alternative xplanation is that nitrite is masked by 
its incorporation into nitrosoproteins. A conse- 
quence of treatment activity is improbable, because 
most patients received the same drugs at the onset 
of the joint effusion, but cannot be excluded. 
Our finding that MC activation products are 
detectable in significant amounts in SF in OA 
confirms and extends the results of Dean et al. [8], 
and suggest that histamine may contribute to 
the effusion of SF with a low cell content. The fact 
that tryptase is able to activate collagenase 
[18] confirms the interest of further studying the 
release of this proteolytic enzyme in rheumatic 
diseases. On the other hand, the recent demon- 
stration that NO enhances apoptosis in chondro- 
cytes [19] suggests that our finding of high nitrite 
levels may help explain the mechanisms underlying 
cartilage breakdown in OA. 
In conclusion, our data confirm the presence of 
MC mediators and NO in SF in OA and suggest 
that these mediators could play a role in the events 
leading to the constitution of joint effusion during 
the course of OA. 
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